Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-12

FDA Approved: LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for the fixed-dose combination of lansoprazole, amoxicillin, and clarithromycin from Rising Pharma Holdings, Inc., for t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lansoprazole, Amoxicillin, Clarithromycin (Lansoprazole; Amoxicillin; Clarithromycin)

Snippet

SUPPL AP for LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN (LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN)